On 20–23 June 2023, the 10th International γδ T cell conference was held in Lisbon, Portugal, bringing together basic, translational and clinical researchers studying γδ T cells in health and disease.
This is a preview of subscription content, log in via an institution to check access.
References
McKenzie, D. R. et al. Nat. Immunol. 23, 411–422 (2022).
Hayday, A. C. & Vantourout, P. Annu. Rev. Immunol. 38, 487–510 (2020).
Willcox, C. R., Mohammed, F. & Willcox, B. E. Immunol. Rev. 298, 25–46 (2020).
Castro, C. D., Boughter, C. T., Broughton, A. E., Ramesh, A. & Adams, E. J. Immunol. Rev. 298, 134–152 (2020).
Vermijlen, D., Gatti, D., Kouzeli, A., Rus, T. & Eberl, M. Semin. Cell. Dev. Biol. 84, 75–86 (2018).
Kaminski, H. et al. J. Infect. Dis. 223, 655–666 (2021).
Pellicci, D. G., Koay, H. F. & Berzins, S. P. Nat. Rev. Immunol. 20, 756–770 (2020).
Sanchez Sanchez, G., Tafesse, Y., Papadopoulou, M. & Vermijlen, D. Immunol. Rev. 315, 89–107 (2023).
Nielsen, M. M., Witherden, D. A. & Havran, W. L. Nat. Rev. Immunol. 17, 733–745 (2017).
Ribot, J. C., Lopes, N. & Silva-Santos, B. Nat. Rev. Immunol. 21, 221–232 (2021).
Mensurado, S., Blanco-Domínguez, R. & Silva-Santos, B. Nat. Rev. Clin. Oncol. 20, 178–191 (2023).
De Vries, N. et al. Nature 613, 743–750 (2023).
Frieling, J. S. et al. Sci. Adv. 9, eadf0108 (2023).
Sanchez Martinez, D. et al. J. Immunother. Cancer 10, e005400 (2022).
Acknowledgements
We thank the local organizing committee, especially N. Gonçalves-Sousa and S. Mensurado, and the scientific partnerships with the Portuguese Society for Immunology and Instituto de Medicina Molecular João Lobo Antunes. We are grateful to all speakers, presenters, chairpersons and helpers for making this conference such a memorable event and would like to apologise to all contributors whose excellent research we have been unable to discuss here due to the tight word limit. We acknowledge A. Hayday for the title of this report, which was inspired by his keynote lecture. The conference was sponsored by Takeda, ImCheck Therapeutics, In8bio, European Federation of Immunological Societies/European Journal of Immunology, American Association for Immunology, Adicet Bio, Phosphogam, New England Biolabs, Biolegend, Miltenyi Biotec and InvivoGen.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
B.S.-S. declares a sponsored research agreement with Takeda on γδ T cell immunotherapy development. E.J.A. declares consultancy with Laguna Therapeutics, TcBioPharm and Notch on γδ T cell immunotherapy development. B.E.W. declares consultancy with Ferring Ventures on γδ T cell immunotherapy development. The other authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Silva-Santos, B., Ribot, J.C., Adams, E.J. et al. γδ T cell explorations seek terra firma. Nat Immunol 24, 1606–1609 (2023). https://doi.org/10.1038/s41590-023-01606-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-023-01606-x
- Springer Nature America, Inc.